Rufinamide 200 mg/1

Rufinamide 200 mg tablets are an anticonvulsant medication used to manage seizures. This film-coated tablet is manufactured by Mylan Pharmaceuticals Inc. and is available in a 120-count plastic bottle.

Rufinamide is primarily used as an adjunctive therapy for seizures associated with Lennox-Gastaut syndrome, a severe form of epilepsy. It works by stabilizing electrical activity in the brain, helping to reduce the frequency and severity of seizures. Rufinamide tablets are designed for oral administration and are typically prescribed as part of a comprehensive treatment plan.

Common effects of rufinamide may include dizziness, headache, and fatigue. Some users may also experience nausea or vomiting. These effects vary among individuals and are not experienced by everyone who takes the medication. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Rufinamide should be handled with care, especially for individuals with a history of heart problems or liver issues. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Keep the medication out of reach of children and store it according to the manufacturer's guidelines.

Rufinamide may interact with other medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain over-the-counter drugs may also affect the efficacy of rufinamide, so it is advisable to consult with a healthcare professional before combining treatments.